Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
-2.36%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$759M
Cap. Flow
% of AUM
-1.62%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| 1 |
Crown Castle
CCI
|
$116M |
| 2 |
Amgen
AMGN
|
$103M |
| 3 |
Progressive
PGR
|
$101M |
| 4 |
AbbVie
ABBV
|
$78.3M |
| 5 |
MetLife
MET
|
$66.2M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$155M |
| 2 |
Johnson & Johnson
JNJ
|
$139M |
| 3 |
LyondellBasell Industries
LYB
|
$106M |
| 4 |
Exxon Mobil
XOM
|
$93.9M |
| 5 |
Apple
AAPL
|
$77.4M |
Sector Composition
| 1 | Technology | 24.49% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.52% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Prudential Financial
PRU
$37.2B
| $7.87M | 0.02% |
82,948
-3,386
| -4% | -$321K |
|
452
Equity Lifestyle Properties
ELS
$12B
| $7.85M | 0.02% |
123,252
-25,533
| -17% | -$1.63M |
|
453
Energy Transfer Partners
ET
$59.7B
| $7.79M | 0.02% |
555,230
| – | – |
|
454
Tarsus Pharmaceuticals
TARS
$2.43B
| $7.78M | 0.02% |
437,891
+195,440
| +81% | +$3.47M |
|
455
H&R Block
HRB
$6.85B
| $7.76M | 0.02% |
180,254
-97,081
| -35% | -$4.18M |
|
456
Manhattan Associates
MANH
$13B
| $7.76M | 0.02% |
39,268
-3,077
| -7% | -$608K |
|
457
Brown & Brown
BRO
$31.3B
| $7.67M | 0.02% |
109,854
-60,336
| -35% | -$4.21M |
|
|
XYZ
458
Block, Inc.
XYZ
$45.7B
| $7.66M | 0.02% |
173,101
-6,474
| -4% | -$287K |
|
459
Genuine Parts
GPC
$19.4B
| $7.65M | 0.02% |
52,975
-37,690
| -42% | -$5.44M |
|
460
United Therapeutics
UTHR
$18.1B
| $7.62M | 0.02% |
33,726
-2,084
| -6% | -$471K |
|
461
NVR
NVR
$23.5B
| $7.52M | 0.02% |
1,261
-734
| -37% | -$4.38M |
|
462
MSCI
MSCI
$42.9B
| $7.48M | 0.02% |
14,588
-5,543
| -28% | -$2.84M |
|
463
Syndax Pharmaceuticals
SNDX
$1.47B
| $7.48M | 0.02% |
514,852
+126,500
| +33% | +$1.84M |
|
464
Madrigal Pharmaceuticals
MDGL
$9.65B
| $7.45M | 0.02% |
51,047
+9,850
| +24% | +$1.44M |
|
465
Quest Diagnostics
DGX
$20.5B
| $7.43M | 0.02% |
60,939
-6,787
| -10% | -$827K |
|
466
Nasdaq
NDAQ
$53.6B
| $7.42M | 0.02% |
152,752
-27,395
| -15% | -$1.33M |
|
467
Fidelity National Financial
FNF
$16.5B
| $7.42M | 0.02% |
179,600
-19,820
| -10% | -$819K |
|
468
Power Integrations
POWI
$2.52B
| $7.37M | 0.02% |
96,525
-990
| -1% | -$75.5K |
|
469
Royal Bank of Canada
RY
$204B
| $7.33M | 0.02% |
83,481
+500
| +0.6% | +$43.9K |
|
470
Ventas
VTR
$30.9B
| $7.33M | 0.02% |
173,934
+44,055
| +34% | +$1.86M |
|
471
Molina Healthcare
MOH
$9.47B
| $7.29M | 0.02% |
22,225
-2,208
| -9% | -$724K |
|
472
Omnicom Group
OMC
$15.4B
| $7.27M | 0.02% |
97,568
+1,600
| +2% | +$119K |
|
473
Repligen
RGEN
$7.01B
| $7.24M | 0.02% |
45,504
+235
| +0.5% | +$37.4K |
|
474
Denali Therapeutics
DNLI
$2.26B
| $7.19M | 0.02% |
348,497
+200,000
| +135% | +$4.13M |
|
|
EXE
475
Expand Energy Corporation Common Stock
EXE
$22.7B
| $7.19M | 0.02% |
83,335
-35,020
| -30% | -$3.02M |
|